| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/25/2001 | CA2379058A1 Pseudomycin prodrugs |
| 01/25/2001 | CA2379022A1 Cyclic peptide derivatives as inhibitors of integrin .alpha.v.beta.6 |
| 01/25/2001 | CA2378954A1 The il-1l1 gene and polypeptide products |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378917A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | CA2378868A1 Process for deacylation of lipodepsipeptides |
| 01/25/2001 | CA2378202A1 New compounds |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2377247A1 Activation and protection of cytotoxic lymphocytes using a reactive oxygen metabolite inhibitor |
| 01/25/2001 | CA2377092A1 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | CA2376518A1 Conversion of a watson-crick dna to a hoogsteen-paired duplex |
| 01/25/2001 | CA2375954A1 Alpha-hydroxy-gamma-¬¬(carbocyclic-or heterocyclic-substituted)amino|carbonyl|alkanamide derivatives and uses thereof |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | CA2374052A1 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | CA2371328A1 Disinfecting composition based on h2o2, acids and metal ions |
| 01/24/2001 | EP1070123A2 Herpes simplex virus latency associated transcript polypeptides |
| 01/24/2001 | EP1070078A2 Form vi 5,6-dichloro-2-(isopropylamino)-1-beta-l-ribofuranosyl)-1h-benzimidazole |
| 01/24/2001 | EP1070077A1 15-membered lactams ketolides with antibacterial activity |
| 01/24/2001 | EP1070069A1 Bicyclic hydroxamic acid derivatives |
| 01/24/2001 | EP1070058A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/24/2001 | EP1069913A1 Gelling ophthalmic compositions containing xanthan gum |
| 01/24/2001 | EP1069910A1 Adjuvant compositions |
| 01/24/2001 | EP1069903A1 Novel nucleoside analogs and uses in treating disease |
| 01/24/2001 | EP1069898A1 Topical antiseptic compositions and methods |
| 01/24/2001 | EP0788513B1 Use of binding agents to cd23 in the treatment of autoimmune diseases |
| 01/24/2001 | EP0706523B1 Substituted arylthioalkylthiopyridines |
| 01/24/2001 | EP0630260B1 Polysaccharide-protein conjugates |
| 01/24/2001 | EP0610377B1 Tri-substituted tetrahydrofuran antifungals |
| 01/24/2001 | CN1281458A Purine compounds having PDE IV inhibitory activity and methods of synthesis |
| 01/24/2001 | CN1281449A Crystalline antifungal polymorph |
| 01/24/2001 | CN1281441A Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors |
| 01/24/2001 | CN1281439A 4-Hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 01/24/2001 | CN1281434A Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors |
| 01/24/2001 | CN1281431A Urethanes, thio and dithio analogues, salts thereof, medicaments containing said compounds, use and method for production thereof |
| 01/24/2001 | CN1281371A Method for obtaining vaccines for preventing pathogenic effects related to retroviral infection |
| 01/24/2001 | CN1280855A Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose |
| 01/24/2001 | CN1280849A Composite medicine for treating tuberculasis |
| 01/24/2001 | CN1280836A Buccal rose lozenge and its preparing process |
| 01/24/2001 | CN1061098C Anti-microbial agents and screening method |
| 01/24/2001 | CN1061095C Process for preparing glycopeptide antibiotics |
| 01/24/2001 | CN1061050C Ureido derivatives of naththalenephosphonic acids and process for their preparation |
| 01/24/2001 | CN1061046C Process for preparing cephalosporins derivants |
| 01/24/2001 | CN1061045C Process for preparation of new cephalosporins containing in position 7 substituted benzyloxyimino radical |
| 01/24/2001 | CN1061044C Tricyclic 5,6-dihydro-9H-pyrazolo [3,4-C]-1,2,4-triaolo [4,3-alpha] pyridines |
| 01/24/2001 | CN1060953C Medicine for curing psoriasis |
| 01/24/2001 | CN1060951C Antiviral veterinary medicine injection and its preparing process |
| 01/24/2001 | CN1060943C Composite pharmaceutics made of oldenlandia for anti-inflammation and clearing away heat and toxic material |
| 01/24/2001 | CN1060937C Use of cow mycobacteria for producing medicine for curing HIV infection patient |
| 01/23/2001 | US6177572 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use |
| 01/23/2001 | US6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 01/23/2001 | US6177469 Antiutor agents; autoimmune diseases |
| 01/23/2001 | US6177464 Bactericides |
| 01/23/2001 | US6177457 Cyclization of chemical intermediates; fungicides |
| 01/23/2001 | US6177436 Administering with viricide; side effect reduction |
| 01/23/2001 | US6177423 N-(hydroxy or protected hydroxy)-benzo(de)isoquinoline-1,3-dione derivatives; bacterial dna gyrase and dna topoisomerase inhibitors useful for antibacterial agents having reduced drug resistance and reduced side effects |
| 01/23/2001 | US6177419 Antioxidant chelate compounds for preventing oxygen free radical-associated diseases in mammals; neuroprotectants, superoxide dismutase (sod), catalase (cat) and/or peroxidase (pod) mimetics |
| 01/23/2001 | US6177408 Compounds such as 3-(1-methyl-4(1-methyl-4(1-methyl-4(4-n,n-bis(2 -chloroethyl)aminocinnamoylamido)pyrrole-2-carboxamido)pyrrole-2 -carboxamido)pyrrole-2-carboxamido)propionamidine |
| 01/23/2001 | US6177402 Promoting survival of mammalian sensory neurons by contacting with leukemia inhibitory factor (lif) |
| 01/23/2001 | US6177086 DNA molecule conferring on Mycobacterium tuberculosis resistance against antimicrobial reactive oxygen and nitrogen intermediates |
| 01/23/2001 | US6177085 Immunology |
| 01/23/2001 | US6177084 S. aureusfibrinogen binding protein |
| 01/23/2001 | US6177083 Immunology to gramnegative bacteria |
| 01/23/2001 | US6177082 Cold-adapted equine influenza viruses |
| 01/23/2001 | US6177081 Human and marmoset activating viruses |
| 01/23/2001 | US6177080 Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy |
| 01/23/2001 | US6177074 Polyethylene glycol modified interferon therapy |
| 01/23/2001 | CA2191790C Biaromatic compounds containing an adamantyl group in para position; pharmaceutical and cosmetic compositions containing them and use thereof |
| 01/18/2001 | WO2001004341A1 Method for producing oligopolysaccharides |
| 01/18/2001 | WO2001004333A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 01/18/2001 | WO2001004328A1 Chlamysin b antibacterial protein, gene encoding it and an expression system for it |
| 01/18/2001 | WO2001004320A1 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
| 01/18/2001 | WO2001004316A2 Antigenic meningococcal peptides |
| 01/18/2001 | WO2001004313A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 01/18/2001 | WO2001004308A1 Human lim domain proteins |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/18/2001 | WO2001004294A1 Antimicrobial peptides derived from molluscs |
| 01/18/2001 | WO2001004282A2 Replication-competent anti-cancer vectors |
| 01/18/2001 | WO2001004272A1 Method to select attenuated paramyxoviridae useful for vaccines and therapeutics |
| 01/18/2001 | WO2001004271A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 01/18/2001 | WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 01/18/2001 | WO2001004148A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/18/2001 | WO2001004140A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | WO2001004134A2 Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them |
| 01/18/2001 | WO2001004127A1 Vinylpyrrolidinone derivatives with substituted thiazole ring |
| 01/18/2001 | WO2001004099A1 Benzoylpyridazines |
| 01/18/2001 | WO2001003749A1 Herb medicine composition to be contained in sanitary materials for infants |
| 01/18/2001 | WO2001003748A1 Herb medicine composition to be spread on sanitary napkin for female |
| 01/18/2001 | WO2001003744A2 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of the c, d or v genes |
| 01/18/2001 | WO2001003737A1 Immunoglobulin fusion proteins |
| 01/18/2001 | WO2001003733A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | WO2001003732A1 Recombinant m. tuberculosis mycobacterium auxotrophic for leucine and vaccines using same |
| 01/18/2001 | WO2001003731A1 Dim mutants of mycobacteria and uses thereof |
| 01/18/2001 | WO2001003730A1 Unmarked deletion mutants of mycobacteria and methods of using same |
| 01/18/2001 | WO2001003729A2 Recombinant envelope vaccine against flavivirus infection |
| 01/18/2001 | WO2001003727A1 Novel methods and medicament for treating infectious diseases involving microbial biofilms |
| 01/18/2001 | WO2001003723A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 01/18/2001 | WO2001003717A2 Methods of inducing cell death |
| 01/18/2001 | WO2001003716A1 Method of treating malignancies and viral infections and improving immune function with a dietary supplement |